Thrivent Financial for Lutherans
DXCM icon

Thrivent Financial for Lutherans’s DexCom DXCM Stock Holding History

Thrivent Financial for Lutherans’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67M Buy
1,067,115
+941,353
+749% +$65.6M 0.13% 187
2025
Q4 		$8.35M Sell
125,762
-50,654
-29% -$3.27M 0.01% 738
2025
Q3 		$11.9M Buy
176,416
+48,749
+38% +$3.86M 0.02% 563
2025
Q2 		$11.1M Sell
127,667
-101,208
-44% -$7.93M 0.02% 530
2025
Q1 		$15.6M Sell
228,875
-52,525
-19% -$4.29M 0.03% 451
2024
Q4 		$21.9M Sell
281,400
-32,702
-10% -$2.42M 0.04% 431
2024
Q3 		$21.1M Buy
314,102
+96,274
+44% +$7.91M 0.04% 453
2024
Q2 		$24.7M Sell
217,828
-11,205
-5% -$1.42M 0.05% 399
2024
Q1 		$31.8M Sell
229,033
-15,352
-6% -$1.93M 0.06% 341
2023
Q4 		$30.3M Buy
244,385
+12,180
+5% +$1.24M 0.07% 330
2023
Q3 		$21.7M Sell
232,205
-682,742
-75% -$77M 0.05% 392
2023
Q2 		$118M Buy
914,947
+68,315
+8% +$8.26M 0.27% 88
2023
Q1 		$98.4M Buy
846,632
+628,201
+288% +$70.3M 0.24% 115
2022
Q4 		$24.7M Sell
218,431
-9,496
-4% -$1.04M 0.06% 364
2022
Q3 		$18.4M Buy
227,927
+1,611
+0.7% +$136K 0.05% 414
2022
Q2 		$16.9M Sell
226,316
-4,488
-2% -$410K 0.04% 438
2022
Q1 		$29.5M Sell
230,804
-619,496
-73% -$67.8M 0.06% 349
2021
Q4 		$114M Sell
850,300
-135,072
-14% -$19.4M 0.22% 114
2021
Q3 		$135M Sell
985,372
-246,976
-20% -$31.1M 0.27% 81
2021
Q2 		$132M Buy
1,232,348
+63,852
+5% +$6.13M 0.27% 84
2021
Q1 		$105M Sell
1,168,496
-7,920
-0.7% -$743K 0.23% 102
2020
Q4 		$109M Buy
1,176,416
+848,696
+259% +$75.8M 0.25% 96
2020
Q3 		$33.8M Sell
327,720
-12,144
-4% -$1.27M 0.09% 264
2020
Q2 		$34.4M Sell
339,864
-78,140
-19% -$6.99M 0.1% 242
2020
Q1 		$28.1M Buy
418,004
+104,920
+34% +$6.53M 0.1% 238
2019
Q4 		$17.1M Buy
313,084
+34,192
+12% +$1.62M 0.05% 419
2019
Q3 		$10.4M Buy
278,892
+6,308
+2% +$245K 0.03% 493
2019
Q2 		$10.2M Sell
272,584
-227,136
-45% -$7.14M 0.03% 510
2019
Q1 		$14.9M Sell
499,720
-69,840
-12% -$2.45M 0.05% 378
2018
Q4 		$17.1M Hold
569,560
– – 0.06% 331
2018
Q3 		$20.4M Sell
569,560
-20,320
-3% -$630K 0.06% 323
2018
Q2 		$14M Hold
589,880
– – 0.05% 400
2018
Q1 		$10.9M Sell
589,880
-50,480
-8% -$746K 0.04% 445
2017
Q4 		$9.19M Buy
640,360
+31,880
+5% +$414K 0.03% 485
2017
Q3 		$7.44M Hold
608,480
– – 0.03% 517
2017
Q2 		$11.1M Buy
608,480
+34,400
+6% +$635K 0.05% 374
2017
Q1 		$12.2M Buy
574,080
+137,600
+32% +$2.69M 0.05% 333
2016
Q4 		$6.51M Buy
436,480
+155,200
+55% +$2.75M 0.03% 505
2016
Q3 		$6.16M Hold
281,280
– – 0.03% 514
2016
Q2 		$5.58M Buy
+281,280
New +$4.79M 0.03% 555

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Thrivent Financial for Lutherans's DXCM Position: Q1 2026 in Review

Thrivent Financial for Lutherans increased its DexCom (DXCM) stake by 749% in Q1 2026, buying an estimated $65.6M and bringing the position to 1,067,115 shares worth $67M. The position accounts for 0.13% of the portfolio, ranked #187.

Thrivent Financial for Lutherans first reported a position in DXCM in Q2 2016 and has held it in 40 quarters since. The position peaked at $135M in Q3 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Thrivent Financial for Lutherans held 1,067,115 shares of DexCom worth $67M as of Q1 2026.
  • Thrivent Financial for Lutherans bought 941,353 DexCom shares in Q1 2026, an estimated $65.6M.
  • DexCom made up 0.13% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #187 holding.
  • Thrivent Financial for Lutherans first reported a position in DexCom in Q2 2016 and has held it in 40 quarters since.
  • Thrivent Financial for Lutherans's DexCom position peaked at $135M in Q3 2021.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.